Global Continuous Subcutaneous Insulin Infusion Devices Market Research Report 2023
Continuous Subcutaneous Insulin Infusion Devices is a medical device used for the administration of insulin in the treatment of diabetes mellitus
According to QYResearch’s new survey, global Continuous Subcutaneous Insulin Infusion Devices market is projected to reach US$ 6119.6 million in 2029, increasing from US$ 4254 million in 2022, with the CAGR of 5.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Continuous Subcutaneous Insulin Infusion Devices market research.
The Insulin Pen and Pump market is primarily driven by the increasing prevalence of diabetes and the need for convenient and accurate insulin delivery methods. Insulin pens and pumps offer user-friendly options for individuals with diabetes to manage their blood sugar levels effectively. The growing awareness of diabetes management, coupled with the advantages of improved dosing accuracy, reduced needle injections, and better glycemic control, contributes to market growth. Moreover, the trend towards personalized medicine and the demand for discreet and easy-to-use devices further propel adoption. However, challenges include patient adherence to treatment regimens, addressing potential technical issues with pumps, and ensuring proper insulin storage for pens. Navigating the competitive landscape and providing education on proper device usage are ongoing concerns. The market's success relies on continuous innovation to enhance device features, comprehensive patient education on insulin management, and collaborations between medical device manufacturers and healthcare professionals to offer reliable, user-centric, and effective insulin pen and pump solutions while addressing the evolving challenges associated with diabetes management.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Continuous Subcutaneous Insulin Infusion Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
According to QYResearch’s new survey, global Continuous Subcutaneous Insulin Infusion Devices market is projected to reach US$ 6119.6 million in 2029, increasing from US$ 4254 million in 2022, with the CAGR of 5.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Continuous Subcutaneous Insulin Infusion Devices market research.
The Insulin Pen and Pump market is primarily driven by the increasing prevalence of diabetes and the need for convenient and accurate insulin delivery methods. Insulin pens and pumps offer user-friendly options for individuals with diabetes to manage their blood sugar levels effectively. The growing awareness of diabetes management, coupled with the advantages of improved dosing accuracy, reduced needle injections, and better glycemic control, contributes to market growth. Moreover, the trend towards personalized medicine and the demand for discreet and easy-to-use devices further propel adoption. However, challenges include patient adherence to treatment regimens, addressing potential technical issues with pumps, and ensuring proper insulin storage for pens. Navigating the competitive landscape and providing education on proper device usage are ongoing concerns. The market's success relies on continuous innovation to enhance device features, comprehensive patient education on insulin management, and collaborations between medical device manufacturers and healthcare professionals to offer reliable, user-centric, and effective insulin pen and pump solutions while addressing the evolving challenges associated with diabetes management.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Continuous Subcutaneous Insulin Infusion Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Medtronic
- Roche
- Insulet Corp
- Tandem Diabetes care
- Valeritas
- SOOIL
- Microport
- Normal Pump
- Patch Pump
- Type I Diabetes
- Type II Diabetes
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
1 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION DEVICES MARKET OVERVIEW
1.1 Product Overview and Scope of Continuous Subcutaneous Insulin Infusion Devices
1.2 Continuous Subcutaneous Insulin Infusion Devices Segment by Type
1.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Market Value Comparison by Type (2023-2029)
1.2.2 Normal Pump
1.2.3 Patch Pump
1.3 Continuous Subcutaneous Insulin Infusion Devices Segment by Application
1.3.1 Global Continuous Subcutaneous Insulin Infusion Devices Market Value by Application: (2023-2029)
1.3.2 Type I Diabetes
1.3.3 Type II Diabetes
1.4 Global Continuous Subcutaneous Insulin Infusion Devices Market Size Estimates and Forecasts
1.4.1 Global Continuous Subcutaneous Insulin Infusion Devices Revenue 2018-2029
1.4.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales 2018-2029
1.4.3 Global Continuous Subcutaneous Insulin Infusion Devices Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION DEVICES MARKET COMPETITION BY MANUFACTURERS
2.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Manufacturers (2018-2023)
2.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Continuous Subcutaneous Insulin Infusion Devices Average Price by Manufacturers (2018-2023)
2.4 Global Continuous Subcutaneous Insulin Infusion Devices Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Continuous Subcutaneous Insulin Infusion Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Continuous Subcutaneous Insulin Infusion Devices, Product Type & Application
2.7 Continuous Subcutaneous Insulin Infusion Devices Market Competitive Situation and Trends
2.7.1 Continuous Subcutaneous Insulin Infusion Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Continuous Subcutaneous Insulin Infusion Devices Players Market Share by Revenue
2.7.3 Global Continuous Subcutaneous Insulin Infusion Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION DEVICES RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Continuous Subcutaneous Insulin Infusion Devices Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Continuous Subcutaneous Insulin Infusion Devices Global Continuous Subcutaneous Insulin Infusion Devices Sales by Region: 2018-2029
3.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales by Region: 2018-2023
3.2.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales by Region: 2024-2029
3.3 Global Continuous Subcutaneous Insulin Infusion Devices Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Region: 2018-2029
3.3.1 Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Region: 2018-2023
3.3.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Region: 2024-2029
3.4 North America Continuous Subcutaneous Insulin Infusion Devices Market Facts & Figures by Country
3.4.1 North America Continuous Subcutaneous Insulin Infusion Devices Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2029)
3.4.3 North America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Continuous Subcutaneous Insulin Infusion Devices Market Facts & Figures by Country
3.5.1 Europe Continuous Subcutaneous Insulin Infusion Devices Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2029)
3.5.3 Europe Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2029)
3.6.3 Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Continuous Subcutaneous Insulin Infusion Devices Market Facts & Figures by Country
3.7.1 Latin America Continuous Subcutaneous Insulin Infusion Devices Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2029)
3.7.3 Latin America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2029)
3.8.3 Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2018-2029)
4.1.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2018-2023)
4.1.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2024-2029)
4.1.3 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2018-2029)
4.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Type (2018-2029)
4.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Type (2018-2023)
4.2.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Type (2024-2029)
4.2.3 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Type (2018-2029)
4.3 Global Continuous Subcutaneous Insulin Infusion Devices Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2018-2029)
5.1.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2018-2023)
5.1.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2024-2029)
5.1.3 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2018-2029)
5.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Application (2018-2029)
5.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Application (2018-2023)
5.2.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Application (2024-2029)
5.2.3 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Application (2018-2029)
5.3 Global Continuous Subcutaneous Insulin Infusion Devices Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Medtronic Continuous Subcutaneous Insulin Infusion Devices Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Roche Continuous Subcutaneous Insulin Infusion Devices Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Insulet Corp
6.3.1 Insulet Corp Corporation Information
6.3.2 Insulet Corp Description and Business Overview
6.3.3 Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Product Portfolio
6.3.5 Insulet Corp Recent Developments/Updates
6.4 Tandem Diabetes care
6.4.1 Tandem Diabetes care Corporation Information
6.4.2 Tandem Diabetes care Description and Business Overview
6.4.3 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Product Portfolio
6.4.5 Tandem Diabetes care Recent Developments/Updates
6.5 Valeritas
6.5.1 Valeritas Corporation Information
6.5.2 Valeritas Description and Business Overview
6.5.3 Valeritas Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Valeritas Continuous Subcutaneous Insulin Infusion Devices Product Portfolio
6.5.5 Valeritas Recent Developments/Updates
6.6 SOOIL
6.6.1 SOOIL Corporation Information
6.6.2 SOOIL Description and Business Overview
6.6.3 SOOIL Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2018-2023)
6.6.4 SOOIL Continuous Subcutaneous Insulin Infusion Devices Product Portfolio
6.6.5 SOOIL Recent Developments/Updates
6.7 Microport
6.6.1 Microport Corporation Information
6.6.2 Microport Description and Business Overview
6.6.3 Microport Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Microport Continuous Subcutaneous Insulin Infusion Devices Product Portfolio
6.7.5 Microport Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Continuous Subcutaneous Insulin Infusion Devices Industry Chain Analysis
7.2 Continuous Subcutaneous Insulin Infusion Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Continuous Subcutaneous Insulin Infusion Devices Production Mode & Process
7.4 Continuous Subcutaneous Insulin Infusion Devices Sales and Marketing
7.4.1 Continuous Subcutaneous Insulin Infusion Devices Sales Channels
7.4.2 Continuous Subcutaneous Insulin Infusion Devices Distributors
7.5 Continuous Subcutaneous Insulin Infusion Devices Customers
8 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION DEVICES MARKET DYNAMICS
8.1 Continuous Subcutaneous Insulin Infusion Devices Industry Trends
8.2 Continuous Subcutaneous Insulin Infusion Devices Market Drivers
8.3 Continuous Subcutaneous Insulin Infusion Devices Market Challenges
8.4 Continuous Subcutaneous Insulin Infusion Devices Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Continuous Subcutaneous Insulin Infusion Devices
1.2 Continuous Subcutaneous Insulin Infusion Devices Segment by Type
1.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Market Value Comparison by Type (2023-2029)
1.2.2 Normal Pump
1.2.3 Patch Pump
1.3 Continuous Subcutaneous Insulin Infusion Devices Segment by Application
1.3.1 Global Continuous Subcutaneous Insulin Infusion Devices Market Value by Application: (2023-2029)
1.3.2 Type I Diabetes
1.3.3 Type II Diabetes
1.4 Global Continuous Subcutaneous Insulin Infusion Devices Market Size Estimates and Forecasts
1.4.1 Global Continuous Subcutaneous Insulin Infusion Devices Revenue 2018-2029
1.4.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales 2018-2029
1.4.3 Global Continuous Subcutaneous Insulin Infusion Devices Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION DEVICES MARKET COMPETITION BY MANUFACTURERS
2.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Manufacturers (2018-2023)
2.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Continuous Subcutaneous Insulin Infusion Devices Average Price by Manufacturers (2018-2023)
2.4 Global Continuous Subcutaneous Insulin Infusion Devices Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Continuous Subcutaneous Insulin Infusion Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Continuous Subcutaneous Insulin Infusion Devices, Product Type & Application
2.7 Continuous Subcutaneous Insulin Infusion Devices Market Competitive Situation and Trends
2.7.1 Continuous Subcutaneous Insulin Infusion Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Continuous Subcutaneous Insulin Infusion Devices Players Market Share by Revenue
2.7.3 Global Continuous Subcutaneous Insulin Infusion Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION DEVICES RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Continuous Subcutaneous Insulin Infusion Devices Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Continuous Subcutaneous Insulin Infusion Devices Global Continuous Subcutaneous Insulin Infusion Devices Sales by Region: 2018-2029
3.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales by Region: 2018-2023
3.2.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales by Region: 2024-2029
3.3 Global Continuous Subcutaneous Insulin Infusion Devices Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Region: 2018-2029
3.3.1 Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Region: 2018-2023
3.3.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Region: 2024-2029
3.4 North America Continuous Subcutaneous Insulin Infusion Devices Market Facts & Figures by Country
3.4.1 North America Continuous Subcutaneous Insulin Infusion Devices Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2029)
3.4.3 North America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Continuous Subcutaneous Insulin Infusion Devices Market Facts & Figures by Country
3.5.1 Europe Continuous Subcutaneous Insulin Infusion Devices Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2029)
3.5.3 Europe Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2029)
3.6.3 Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Continuous Subcutaneous Insulin Infusion Devices Market Facts & Figures by Country
3.7.1 Latin America Continuous Subcutaneous Insulin Infusion Devices Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2029)
3.7.3 Latin America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2029)
3.8.3 Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2018-2029)
4.1.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2018-2023)
4.1.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2024-2029)
4.1.3 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2018-2029)
4.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Type (2018-2029)
4.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Type (2018-2023)
4.2.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Type (2024-2029)
4.2.3 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Type (2018-2029)
4.3 Global Continuous Subcutaneous Insulin Infusion Devices Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2018-2029)
5.1.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2018-2023)
5.1.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2024-2029)
5.1.3 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2018-2029)
5.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Application (2018-2029)
5.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Application (2018-2023)
5.2.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Application (2024-2029)
5.2.3 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Application (2018-2029)
5.3 Global Continuous Subcutaneous Insulin Infusion Devices Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Medtronic Continuous Subcutaneous Insulin Infusion Devices Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Roche Continuous Subcutaneous Insulin Infusion Devices Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Insulet Corp
6.3.1 Insulet Corp Corporation Information
6.3.2 Insulet Corp Description and Business Overview
6.3.3 Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Product Portfolio
6.3.5 Insulet Corp Recent Developments/Updates
6.4 Tandem Diabetes care
6.4.1 Tandem Diabetes care Corporation Information
6.4.2 Tandem Diabetes care Description and Business Overview
6.4.3 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Product Portfolio
6.4.5 Tandem Diabetes care Recent Developments/Updates
6.5 Valeritas
6.5.1 Valeritas Corporation Information
6.5.2 Valeritas Description and Business Overview
6.5.3 Valeritas Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Valeritas Continuous Subcutaneous Insulin Infusion Devices Product Portfolio
6.5.5 Valeritas Recent Developments/Updates
6.6 SOOIL
6.6.1 SOOIL Corporation Information
6.6.2 SOOIL Description and Business Overview
6.6.3 SOOIL Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2018-2023)
6.6.4 SOOIL Continuous Subcutaneous Insulin Infusion Devices Product Portfolio
6.6.5 SOOIL Recent Developments/Updates
6.7 Microport
6.6.1 Microport Corporation Information
6.6.2 Microport Description and Business Overview
6.6.3 Microport Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Microport Continuous Subcutaneous Insulin Infusion Devices Product Portfolio
6.7.5 Microport Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Continuous Subcutaneous Insulin Infusion Devices Industry Chain Analysis
7.2 Continuous Subcutaneous Insulin Infusion Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Continuous Subcutaneous Insulin Infusion Devices Production Mode & Process
7.4 Continuous Subcutaneous Insulin Infusion Devices Sales and Marketing
7.4.1 Continuous Subcutaneous Insulin Infusion Devices Sales Channels
7.4.2 Continuous Subcutaneous Insulin Infusion Devices Distributors
7.5 Continuous Subcutaneous Insulin Infusion Devices Customers
8 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION DEVICES MARKET DYNAMICS
8.1 Continuous Subcutaneous Insulin Infusion Devices Industry Trends
8.2 Continuous Subcutaneous Insulin Infusion Devices Market Drivers
8.3 Continuous Subcutaneous Insulin Infusion Devices Market Challenges
8.4 Continuous Subcutaneous Insulin Infusion Devices Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Continuous Subcutaneous Insulin Infusion Devices Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Continuous Subcutaneous Insulin Infusion Devices Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Continuous Subcutaneous Insulin Infusion Devices Market Competitive Situation by Manufacturers in 2022
Table 4. Global Continuous Subcutaneous Insulin Infusion Devices Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Continuous Subcutaneous Insulin Infusion Devices Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Continuous Subcutaneous Insulin Infusion Devices Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Continuous Subcutaneous Insulin Infusion Devices, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Continuous Subcutaneous Insulin Infusion Devices, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Continuous Subcutaneous Insulin Infusion Devices, Product Type & Application
Table 12. Global Key Manufacturers of Continuous Subcutaneous Insulin Infusion Devices, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Continuous Subcutaneous Insulin Infusion Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Subcutaneous Insulin Infusion Devices as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Continuous Subcutaneous Insulin Infusion Devices Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Region (2018-2023) & (K Units)
Table 18. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Region (2018-2023)
Table 19. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Region (2024-2029) & (K Units)
Table 20. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Region (2024-2029)
Table 21. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Region (2018-2023)
Table 23. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Region (2024-2029)
Table 25. North America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2023) & (K Units)
Table 27. North America Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2024-2029) & (K Units)
Table 28. North America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2023) & (K Units)
Table 32. Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2024-2029) & (K Units)
Table 33. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Continuous Subcutaneous Insulin Infusion Devices Sales (K Units) by Type (2018-2023)
Table 51. Global Continuous Subcutaneous Insulin Infusion Devices Sales (K Units) by Type (2024-2029)
Table 52. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2018-2023)
Table 53. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2024-2029)
Table 54. Global Continuous Subcutaneous Insulin Infusion Devices Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Continuous Subcutaneous Insulin Infusion Devices Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Type (2018-2023)
Table 57. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Type (2024-2029)
Table 58. Global Continuous Subcutaneous Insulin Infusion Devices Price (US$/Unit) by Type (2018-2023)
Table 59. Global Continuous Subcutaneous Insulin Infusion Devices Price (US$/Unit) by Type (2024-2029)
Table 60. Global Continuous Subcutaneous Insulin Infusion Devices Sales (K Units) by Application (2018-2023)
Table 61. Global Continuous Subcutaneous Insulin Infusion Devices Sales (K Units) by Application (2024-2029)
Table 62. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2018-2023)
Table 63. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2024-2029)
Table 64. Global Continuous Subcutaneous Insulin Infusion Devices Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Continuous Subcutaneous Insulin Infusion Devices Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Application (2018-2023)
Table 67. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Application (2024-2029)
Table 68. Global Continuous Subcutaneous Insulin Infusion Devices Price (US$/Unit) by Application (2018-2023)
Table 69. Global Continuous Subcutaneous Insulin Infusion Devices Price (US$/Unit) by Application (2024-2029)
Table 70. Medtronic Corporation Information
Table 71. Medtronic Description and Business Overview
Table 72. Medtronic Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Medtronic Continuous Subcutaneous Insulin Infusion Devices Product
Table 74. Medtronic Recent Developments/Updates
Table 75. Roche Corporation Information
Table 76. Roche Description and Business Overview
Table 77. Roche Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Roche Continuous Subcutaneous Insulin Infusion Devices Product
Table 79. Roche Recent Developments/Updates
Table 80. Insulet Corp Corporation Information
Table 81. Insulet Corp Description and Business Overview
Table 82. Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Product
Table 84. Insulet Corp Recent Developments/Updates
Table 85. Tandem Diabetes care Corporation Information
Table 86. Tandem Diabetes care Description and Business Overview
Table 87. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Product
Table 89. Tandem Diabetes care Recent Developments/Updates
Table 90. Valeritas Corporation Information
Table 91. Valeritas Description and Business Overview
Table 92. Valeritas Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Valeritas Continuous Subcutaneous Insulin Infusion Devices Product
Table 94. Valeritas Recent Developments/Updates
Table 95. SOOIL Corporation Information
Table 96. SOOIL Description and Business Overview
Table 97. SOOIL Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. SOOIL Continuous Subcutaneous Insulin Infusion Devices Product
Table 99. SOOIL Recent Developments/Updates
Table 100. Microport Corporation Information
Table 101. Microport Description and Business Overview
Table 102. Microport Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Microport Continuous Subcutaneous Insulin Infusion Devices Product
Table 104. Microport Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Continuous Subcutaneous Insulin Infusion Devices Distributors List
Table 108. Continuous Subcutaneous Insulin Infusion Devices Customers List
Table 109. Continuous Subcutaneous Insulin Infusion Devices Market Trends
Table 110. Continuous Subcutaneous Insulin Infusion Devices Market Drivers
Table 111. Continuous Subcutaneous Insulin Infusion Devices Market Challenges
Table 112. Continuous Subcutaneous Insulin Infusion Devices Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 1. Global Continuous Subcutaneous Insulin Infusion Devices Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Continuous Subcutaneous Insulin Infusion Devices Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Continuous Subcutaneous Insulin Infusion Devices Market Competitive Situation by Manufacturers in 2022
Table 4. Global Continuous Subcutaneous Insulin Infusion Devices Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Continuous Subcutaneous Insulin Infusion Devices Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Continuous Subcutaneous Insulin Infusion Devices Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Continuous Subcutaneous Insulin Infusion Devices, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Continuous Subcutaneous Insulin Infusion Devices, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Continuous Subcutaneous Insulin Infusion Devices, Product Type & Application
Table 12. Global Key Manufacturers of Continuous Subcutaneous Insulin Infusion Devices, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Continuous Subcutaneous Insulin Infusion Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Subcutaneous Insulin Infusion Devices as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Continuous Subcutaneous Insulin Infusion Devices Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Region (2018-2023) & (K Units)
Table 18. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Region (2018-2023)
Table 19. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Region (2024-2029) & (K Units)
Table 20. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Region (2024-2029)
Table 21. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Region (2018-2023)
Table 23. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Region (2024-2029)
Table 25. North America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2023) & (K Units)
Table 27. North America Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2024-2029) & (K Units)
Table 28. North America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2023) & (K Units)
Table 32. Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2024-2029) & (K Units)
Table 33. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Continuous Subcutaneous Insulin Infusion Devices Sales (K Units) by Type (2018-2023)
Table 51. Global Continuous Subcutaneous Insulin Infusion Devices Sales (K Units) by Type (2024-2029)
Table 52. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2018-2023)
Table 53. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2024-2029)
Table 54. Global Continuous Subcutaneous Insulin Infusion Devices Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Continuous Subcutaneous Insulin Infusion Devices Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Type (2018-2023)
Table 57. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Type (2024-2029)
Table 58. Global Continuous Subcutaneous Insulin Infusion Devices Price (US$/Unit) by Type (2018-2023)
Table 59. Global Continuous Subcutaneous Insulin Infusion Devices Price (US$/Unit) by Type (2024-2029)
Table 60. Global Continuous Subcutaneous Insulin Infusion Devices Sales (K Units) by Application (2018-2023)
Table 61. Global Continuous Subcutaneous Insulin Infusion Devices Sales (K Units) by Application (2024-2029)
Table 62. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2018-2023)
Table 63. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2024-2029)
Table 64. Global Continuous Subcutaneous Insulin Infusion Devices Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Continuous Subcutaneous Insulin Infusion Devices Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Application (2018-2023)
Table 67. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Application (2024-2029)
Table 68. Global Continuous Subcutaneous Insulin Infusion Devices Price (US$/Unit) by Application (2018-2023)
Table 69. Global Continuous Subcutaneous Insulin Infusion Devices Price (US$/Unit) by Application (2024-2029)
Table 70. Medtronic Corporation Information
Table 71. Medtronic Description and Business Overview
Table 72. Medtronic Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Medtronic Continuous Subcutaneous Insulin Infusion Devices Product
Table 74. Medtronic Recent Developments/Updates
Table 75. Roche Corporation Information
Table 76. Roche Description and Business Overview
Table 77. Roche Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Roche Continuous Subcutaneous Insulin Infusion Devices Product
Table 79. Roche Recent Developments/Updates
Table 80. Insulet Corp Corporation Information
Table 81. Insulet Corp Description and Business Overview
Table 82. Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Product
Table 84. Insulet Corp Recent Developments/Updates
Table 85. Tandem Diabetes care Corporation Information
Table 86. Tandem Diabetes care Description and Business Overview
Table 87. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Product
Table 89. Tandem Diabetes care Recent Developments/Updates
Table 90. Valeritas Corporation Information
Table 91. Valeritas Description and Business Overview
Table 92. Valeritas Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Valeritas Continuous Subcutaneous Insulin Infusion Devices Product
Table 94. Valeritas Recent Developments/Updates
Table 95. SOOIL Corporation Information
Table 96. SOOIL Description and Business Overview
Table 97. SOOIL Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. SOOIL Continuous Subcutaneous Insulin Infusion Devices Product
Table 99. SOOIL Recent Developments/Updates
Table 100. Microport Corporation Information
Table 101. Microport Description and Business Overview
Table 102. Microport Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Microport Continuous Subcutaneous Insulin Infusion Devices Product
Table 104. Microport Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Continuous Subcutaneous Insulin Infusion Devices Distributors List
Table 108. Continuous Subcutaneous Insulin Infusion Devices Customers List
Table 109. Continuous Subcutaneous Insulin Infusion Devices Market Trends
Table 110. Continuous Subcutaneous Insulin Infusion Devices Market Drivers
Table 111. Continuous Subcutaneous Insulin Infusion Devices Market Challenges
Table 112. Continuous Subcutaneous Insulin Infusion Devices Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Continuous Subcutaneous Insulin Infusion Devices
Figure 2. Global Continuous Subcutaneous Insulin Infusion Devices Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Continuous Subcutaneous Insulin Infusion Devices Market Share by Type in 2022 & 2029
Figure 4. Normal Pump Product Picture
Figure 5. Patch Pump Product Picture
Figure 6. Global Continuous Subcutaneous Insulin Infusion Devices Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Continuous Subcutaneous Insulin Infusion Devices Market Share by Application in 2022 & 2029
Figure 8. Type I Diabetes
Figure 9. Type II Diabetes
Figure 10. Global Continuous Subcutaneous Insulin Infusion Devices Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Continuous Subcutaneous Insulin Infusion Devices Market Size (2018-2029) & (US$ Million)
Figure 12. Global Continuous Subcutaneous Insulin Infusion Devices Sales (2018-2029) & (K Units)
Figure 13. Global Continuous Subcutaneous Insulin Infusion Devices Average Price (US$/Unit) & (2018-2029)
Figure 14. Continuous Subcutaneous Insulin Infusion Devices Report Years Considered
Figure 15. Continuous Subcutaneous Insulin Infusion Devices Sales Share by Manufacturers in 2022
Figure 16. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Continuous Subcutaneous Insulin Infusion Devices Players: Market Share by Revenue in 2022
Figure 18. Continuous Subcutaneous Insulin Infusion Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Continuous Subcutaneous Insulin Infusion Devices Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country (2018-2029)
Figure 21. North America Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country (2018-2029)
Figure 22. United States Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country (2018-2029)
Figure 25. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country (2018-2029)
Figure 26. Germany Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Region (2018-2029)
Figure 33. China Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country (2018-2029)
Figure 43. Latin America Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Continuous Subcutaneous Insulin Infusion Devices by Type (2018-2029)
Figure 53. Global Revenue Market Share of Continuous Subcutaneous Insulin Infusion Devices by Type (2018-2029)
Figure 54. Global Continuous Subcutaneous Insulin Infusion Devices Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Continuous Subcutaneous Insulin Infusion Devices by Application (2018-2029)
Figure 56. Global Revenue Market Share of Continuous Subcutaneous Insulin Infusion Devices by Application (2018-2029)
Figure 57. Global Continuous Subcutaneous Insulin Infusion Devices Price (US$/Unit) by Application (2018-2029)
Figure 58. Continuous Subcutaneous Insulin Infusion Devices Value Chain
Figure 59. Continuous Subcutaneous Insulin Infusion Devices Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Figure 1. Product Picture of Continuous Subcutaneous Insulin Infusion Devices
Figure 2. Global Continuous Subcutaneous Insulin Infusion Devices Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Continuous Subcutaneous Insulin Infusion Devices Market Share by Type in 2022 & 2029
Figure 4. Normal Pump Product Picture
Figure 5. Patch Pump Product Picture
Figure 6. Global Continuous Subcutaneous Insulin Infusion Devices Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Continuous Subcutaneous Insulin Infusion Devices Market Share by Application in 2022 & 2029
Figure 8. Type I Diabetes
Figure 9. Type II Diabetes
Figure 10. Global Continuous Subcutaneous Insulin Infusion Devices Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Continuous Subcutaneous Insulin Infusion Devices Market Size (2018-2029) & (US$ Million)
Figure 12. Global Continuous Subcutaneous Insulin Infusion Devices Sales (2018-2029) & (K Units)
Figure 13. Global Continuous Subcutaneous Insulin Infusion Devices Average Price (US$/Unit) & (2018-2029)
Figure 14. Continuous Subcutaneous Insulin Infusion Devices Report Years Considered
Figure 15. Continuous Subcutaneous Insulin Infusion Devices Sales Share by Manufacturers in 2022
Figure 16. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Continuous Subcutaneous Insulin Infusion Devices Players: Market Share by Revenue in 2022
Figure 18. Continuous Subcutaneous Insulin Infusion Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Continuous Subcutaneous Insulin Infusion Devices Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country (2018-2029)
Figure 21. North America Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country (2018-2029)
Figure 22. United States Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country (2018-2029)
Figure 25. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country (2018-2029)
Figure 26. Germany Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Region (2018-2029)
Figure 33. China Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country (2018-2029)
Figure 43. Latin America Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Continuous Subcutaneous Insulin Infusion Devices by Type (2018-2029)
Figure 53. Global Revenue Market Share of Continuous Subcutaneous Insulin Infusion Devices by Type (2018-2029)
Figure 54. Global Continuous Subcutaneous Insulin Infusion Devices Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Continuous Subcutaneous Insulin Infusion Devices by Application (2018-2029)
Figure 56. Global Revenue Market Share of Continuous Subcutaneous Insulin Infusion Devices by Application (2018-2029)
Figure 57. Global Continuous Subcutaneous Insulin Infusion Devices Price (US$/Unit) by Application (2018-2029)
Figure 58. Continuous Subcutaneous Insulin Infusion Devices Value Chain
Figure 59. Continuous Subcutaneous Insulin Infusion Devices Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
